Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.52 AUD | -4.59% | +7.22% | -21.80% |
Apr. 19 | INOVIQ Concludes Analytical Validation for Ovarian Cancer Blood Test | MT |
Apr. 15 | Fears of Middle East Conflict Escalation Quell Appetite for Australian Shares | MT |
Sales 2024 * | 900K 598K | Sales 2025 * | 1.6M 1.06M | Capitalization | 50.15M 33.3M |
---|---|---|---|---|---|
Net income 2024 * | -9M -5.98M | Net income 2025 * | -8M -5.31M | EV / Sales 2024 * | 47.8 x |
Net cash position 2024 * | 7.1M 4.72M | Net cash position 2025 * | 8.9M 5.91M | EV / Sales 2025 * | 25.8 x |
P/E ratio 2024 * |
-5.56
x | P/E ratio 2025 * |
-7.27
x | Employees | 15 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 71.68% |
1 day | -4.59% | ||
1 week | +7.22% | ||
Current month | +4.00% | ||
1 month | -20.00% | ||
3 months | -5.45% | ||
6 months | -19.38% | ||
Current year | -21.80% |
Managers | Title | Age | Since |
---|---|---|---|
Leearne Hinch
CEO | Chief Executive Officer | - | 16-11-06 |
Mark Edwards
DFI | Director of Finance/CFO | - | 22-11-01 |
Gregory Rice
CTO | Chief Tech/Sci/R&D Officer | - | 21-09-19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 70 | Nov. 28 | |
Philip Powell
BRD | Director/Board Member | 65 | 19-06-17 |
Geoff Cumming
BRD | Director/Board Member | - | 20-07-27 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-15 | 0.52 | -4.59% | 16 445 |
24-05-14 | 0.545 | +4.81% | 56,125 |
24-05-13 | 0.52 | -1.89% | 44,376 |
24-05-10 | 0.53 | +7.07% | 47,065 |
24-05-09 | 0.495 | +2.06% | 66,843 |
Delayed Quote Australian S.E., May 15, 2024 at 01:59 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-21.80% | 33.21M | |
+29.03% | 49.18B | |
-0.10% | 42.11B | |
+47.81% | 40.37B | |
-5.26% | 28.85B | |
+11.48% | 26.09B | |
-22.74% | 18.71B | |
+9.06% | 13.26B | |
+30.01% | 12.32B | |
-1.51% | 11.99B |
- Stock Market
- Equities
- IIQ Stock